Lancet (London, England) - JoVE Visualize

Showing results (391-400 of 19,456) with videos related to

Pageof 1,946

Sort By:

Lancet (London, England)|July 4, 1987

Persistent measles virus genome in autoimmune chronic active hepatitisD A Robertson, S L Zhang, E C Guy, et al.

Lancet (London, England)|July 11, 1987

Sensitive assays for viral antibodies in saliva: an alternative to tests on serumJ V Parry, K R Perry, P P Mortimer

Lancet (London, England)|July 11, 1987

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapyJ Pedersen-Bjergaard, L Specht, S O Larsen, et al.

Lancet (London, England)|July 18, 1987

Diagnosis of tuberculous meningitis by detection of tuberculostearic acid in cerebrospinal fluidG L French, R Teoh, C Y Chan, et al.

Lancet (London, England)|July 18, 1987

Circulating cytotoxic protein generated after ethanol consumption: identification and mechanism of reaction with cellsS N Wickramasinghe, B Gardner, G Barden

Lancet (London, England)|September 3, 2017

Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort studyVictoria Miller, Andrew Mente, Mahshid Dehghan, et al.

Lancet (London, England)|August 1, 1987

Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patientsJ A Tayek, D Heber, R T Chlebowski

Lancet (London, England)|August 1, 1987

Endemic goitre in central China caused by excessive iodine intakeM Li, D R Liu, C Y Qu, et al.

Lancet (London, England)|August 1, 1987

Postural body sway and exposure to high-energy impulse noiseJ Juntunen, E Matikainen, J Ylikoski, et al.

Lancet (London, England)|September 5, 2017

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trialPaul E Sax, Anton Pozniak, M Luisa Montes, et al.

Pageof 1,946

Showing results (391-400 of 19,456) with videos related to

Sort By:

Pageof 1,946

Lancet (London, England)|July 4, 1987

Persistent measles virus genome in autoimmune chronic active hepatitisD A Robertson, S L Zhang, E C Guy, et al.

Lancet (London, England)|July 11, 1987

Sensitive assays for viral antibodies in saliva: an alternative to tests on serumJ V Parry, K R Perry, P P Mortimer

Lancet (London, England)|July 11, 1987

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapyJ Pedersen-Bjergaard, L Specht, S O Larsen, et al.

Lancet (London, England)|July 18, 1987

Diagnosis of tuberculous meningitis by detection of tuberculostearic acid in cerebrospinal fluidG L French, R Teoh, C Y Chan, et al.

Lancet (London, England)|July 18, 1987

Circulating cytotoxic protein generated after ethanol consumption: identification and mechanism of reaction with cellsS N Wickramasinghe, B Gardner, G Barden

Lancet (London, England)|September 3, 2017

Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort studyVictoria Miller, Andrew Mente, Mahshid Dehghan, et al.

Lancet (London, England)|August 1, 1987

Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patientsJ A Tayek, D Heber, R T Chlebowski

Lancet (London, England)|August 1, 1987

Endemic goitre in central China caused by excessive iodine intakeM Li, D R Liu, C Y Qu, et al.

Lancet (London, England)|August 1, 1987

Postural body sway and exposure to high-energy impulse noiseJ Juntunen, E Matikainen, J Ylikoski, et al.

Lancet (London, England)|September 5, 2017

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trialPaul E Sax, Anton Pozniak, M Luisa Montes, et al.

Pageof 1,946